SynthesisFrontiers in immunology2026

Antibody-based regimens targeting PD-1/PD-L1 and VEGF/VEGFR in advanced or metastatic NSCLC: a meta-analysis of RCTs.

Wenjie Mao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.